Literature DB >> 24271457

Grading of evidence for bladder pain syndrome: a comparative review of study quality assessment methods.

S A Tirlapur1, K S Khan.   

Abstract

INTRODUCTION AND HYPOTHESIS: Clinical guidelines on bladder pain syndrome (BPS) report quality ratings for evidence based on study design. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) system takes into account several domains in addition to limitations of study design for assigning quality ratings. We compared the quality of evidence described in current BPS literature.
METHODS: All existing systematic reviews and guidelines on BPS management were reviewed, and included evidence was rated according to GRADE on a four-point scale (1-4, from very low to high). These ratings were compared to the two reported quality assessments that assigned levels or strengths to evidence; both had a four-point scale: level of evidence 1-4 from meta-analysis of randomised studies to expert opinion; and strength of evidence 1-4 from very low to high.
RESULTS: Of the 19 treatments for BPS with GRADE ratings, comparison with level of evidence ratings showed that, on average, the latter overestimated quality by 1.8 points [1.1 v 2.9; 95% confidence interval (CI) 1.2-2.3; p = <0.0001). Comparison of GRADE ratings with strength of evidence ratings showed that, on average, the latter overestimated quality by 1.7 points (1.1 v 2.8; 95% CI 1.3-2.1; p = <0.0001).
CONCLUSION: GRADE, a refined method of assigning quality to evidence, provided a more conservative gauge, giving a realistic assessment of the value of recommendations for consideration in practice.

Entities:  

Mesh:

Year:  2013        PMID: 24271457     DOI: 10.1007/s00192-013-2266-9

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  47 in total

1.  Grading quality of evidence and strength of recommendations.

Authors:  David Atkins; Dana Best; Peter A Briss; Martin Eccles; Yngve Falck-Ytter; Signe Flottorp; Gordon H Guyatt; Robin T Harbour; Margaret C Haugh; David Henry; Suzanne Hill; Roman Jaeschke; Gillian Leng; Alessandro Liberati; Nicola Magrini; James Mason; Philippa Middleton; Jacek Mrukowicz; Dianne O'Connell; Andrew D Oxman; Bob Phillips; Holger J Schünemann; Tessa Tan-Torres Edejer; Helena Varonen; Gunn E Vist; John W Williams; Stephanie Zaza
Journal:  BMJ       Date:  2004-06-19

Review 2.  Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions.

Authors:  J L Brozek; E A Akl; P Alonso-Coello; D Lang; R Jaeschke; J W Williams; B Phillips; M Lelgemann; A Lethaby; J Bousquet; G H Guyatt; H J Schünemann
Journal:  Allergy       Date:  2009-05       Impact factor: 13.146

Review 3.  What do we know about tocolytic effectiveness and how do we use this information in guidelines? A comparison of evidence grading.

Authors:  C Roos; E Borowiack; M Kowalska; A Zapalska; Bw Mol; L Mignini; C Meads; J Walczak; Ks Khan
Journal:  BJOG       Date:  2013-09-10       Impact factor: 6.531

Review 4.  Intravesical botulinum toxin A injections in the treatment of painful bladder syndrome/interstitial cystitis: a systematic review.

Authors:  Sahithi Tirumuru; Deyaa Al-Kurdi; Pallavi Latthe
Journal:  Int Urogynecol J       Date:  2010-05-07       Impact factor: 2.894

5.  Percutaneous sacral nerve root neuromodulation for intractable interstitial cystitis.

Authors:  C F Maher; M P Carey; P L Dwyer; P L Schluter
Journal:  J Urol       Date:  2001-03       Impact factor: 7.450

6.  Japanese guideline for diagnosis and treatment of interstitial cystitis.

Authors:  Yukio Homma; Tomohiro Ueda; Takaaki Ito; Mineo Takei; Hikaru Tomoe
Journal:  Int J Urol       Date:  2009-01       Impact factor: 3.369

7.  Posterior tibial nerve stimulation twice a week in patients with interstitial cystitis.

Authors:  Jimao Zhao; Jie Bai; Ying Zhou; Guihua Qi; Lingdong Du
Journal:  Urology       Date:  2008-04-18       Impact factor: 2.649

Review 8.  Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal.

Authors:  Joop P van de Merwe; Jørgen Nordling; Pierre Bouchelouche; Kirsten Bouchelouche; Mauro Cervigni; L Kurosch Daha; Suzy Elneil; Magnus Fall; Gero Hohlbrugger; Paul Irwin; Svend Mortensen; Arndt van Ophoven; John L Osborne; Ralph Peeker; Benedikte Richter; Claus Riedl; Jukka Sairanen; Martina Tinzl; Jean-Jacques Wyndaele
Journal:  Eur Urol       Date:  2007-09-20       Impact factor: 20.096

9.  Followup of patients with interstitial cystitis responsive to treatment with intravesical bacillus Calmette-Guerin or placebo.

Authors:  Kathleen Joy Propert; Robert Mayer; J Curtis Nickel; Christopher K Payne; Kenneth M Peters; Valerie Teal; David Burks; John W Kusek; Leroy M Nyberg; Harris E Foster
Journal:  J Urol       Date:  2007-12-21       Impact factor: 7.450

Review 10.  AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome.

Authors:  Philip M Hanno; David Allen Burks; J Quentin Clemens; Roger R Dmochowski; Deborah Erickson; Mary Pat Fitzgerald; John B Forrest; Barbara Gordon; Mikel Gray; Robert Dale Mayer; Diane Newman; Leroy Nyberg; Christopher K Payne; Ursula Wesselmann; Martha M Faraday
Journal:  J Urol       Date:  2011-04-16       Impact factor: 7.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.